KATALYST Life Sciences
ActiveSummary
KATALYST Life Sciences has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €317,784 and a net result of -€6,729. Equity is growing by about 20% per year across the filed financial years. Its solvency ranks better than 95% of 612 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Directors
Directors
No directors read yet: 1 of 2 Gazette acts processed. See the directors and other office holders in the KBO →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.